JP2011512349A5 - - Google Patents

Download PDF

Info

Publication number
JP2011512349A5
JP2011512349A5 JP2010546446A JP2010546446A JP2011512349A5 JP 2011512349 A5 JP2011512349 A5 JP 2011512349A5 JP 2010546446 A JP2010546446 A JP 2010546446A JP 2010546446 A JP2010546446 A JP 2010546446A JP 2011512349 A5 JP2011512349 A5 JP 2011512349A5
Authority
JP
Japan
Prior art keywords
layer
release
coating
alcohol
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010546446A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011512349A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2009/000106 external-priority patent/WO2009122431A2/en
Publication of JP2011512349A publication Critical patent/JP2011512349A/ja
Publication of JP2011512349A5 publication Critical patent/JP2011512349A5/ja
Pending legal-status Critical Current

Links

JP2010546446A 2008-02-15 2009-02-16 経口放出制御錠剤 Pending JP2011512349A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN339MU2008 2008-02-15
PCT/IN2009/000106 WO2009122431A2 (en) 2008-02-15 2009-02-16 Oral controlled release tablet

Publications (2)

Publication Number Publication Date
JP2011512349A JP2011512349A (ja) 2011-04-21
JP2011512349A5 true JP2011512349A5 (OSRAM) 2012-04-05

Family

ID=40955347

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010546446A Pending JP2011512349A (ja) 2008-02-15 2009-02-16 経口放出制御錠剤

Country Status (10)

Country Link
US (1) US20090208572A1 (OSRAM)
EP (1) EP2242485A4 (OSRAM)
JP (1) JP2011512349A (OSRAM)
KR (1) KR20100136967A (OSRAM)
CN (1) CN102026628A (OSRAM)
BR (1) BRPI0908114A2 (OSRAM)
CA (1) CA2715584A1 (OSRAM)
MX (1) MX2010008861A (OSRAM)
WO (1) WO2009122431A2 (OSRAM)
ZA (1) ZA201006793B (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7465456B2 (en) * 2002-04-26 2008-12-16 Medimmune, Llc Multi plasmid system for the production of influenza virus
US20050158342A1 (en) * 2003-12-23 2005-07-21 Medimmune, Inc. Multi plasmid system for the production of influenza virus
CN103540613A (zh) * 2002-04-26 2014-01-29 米迪缪尼有限公司 制备流感病毒的多质粒系统
AU2003258289A1 (en) 2002-08-19 2004-03-03 The Trustees Of Columbia University In The City Of New York A single-shot semiconductor processing system and method having various irradiation patterns
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
JP5666905B2 (ja) * 2007-06-18 2015-02-12 メディミューン，エルエルシー ヘマグルチニンポリペプチド中に変化を有するインフルエンザｂウイルス
KR20140069381A (ko) * 2009-06-02 2014-06-10 다우 글로벌 테크놀로지스 엘엘씨 서방출 투여형
JP2013504562A (ja) * 2009-09-17 2013-02-07 カディラ・ヘルスケア・リミテッド アルコールで誘発される用量ダンピングを低減するための医薬組成物
US8901113B2 (en) * 2009-09-30 2014-12-02 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
EP2714015B1 (en) * 2011-06-01 2017-03-15 FMC Corporation Controlled release solid dose forms
CN104968333B (zh) 2012-11-30 2018-07-10 阿库拉制药公司 活性药物成分的自调节释放
US9675587B2 (en) 2013-03-14 2017-06-13 Allergan Holdings Unlimited Company Opioid receptor modulator dosage formulations
JP5941117B2 (ja) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
EA030138B1 (ru) * 2016-06-15 2018-06-29 Общество С Ограниченной Ответственностью "Фармадиол" Фармацевтические композиции, включающие антикоагулянт n-(5-хлорпиридин-2-ил)-2-({4-[этанимидоил(метил)амино]бензоил}амино)-5-метилбензамид
IT201800011125A1 (it) * 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide comprendenti matrici monolitiche complesse per la somministrazione cronotropica di medicamenti nel tratto gastroenterico
WO2021224471A1 (en) * 2020-05-08 2021-11-11 Janssen Pharmaceutica Nv Pharmaceutical formulations of abiraterone acetate and niraparib
WO2025137498A1 (en) * 2023-12-20 2025-06-26 Areteia Therapeutics, Inc. Matrix tablets of dexpramipexole and methods of manufacturing and use thereof
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4519801A (en) * 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4693896A (en) * 1985-10-07 1987-09-15 Fmc Corporation Ethylcellulose-coated, gastric-disintegrable aspirin tablet
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US5271946A (en) * 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
DE69229881T2 (de) * 1991-10-04 1999-12-09 Yoshitomi Pharmaceutical Industries, Ltd. Tablette mit verzögerter freisetzung
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
ATE128363T1 (de) * 1993-05-15 1995-10-15 Boehringer Mannheim Gmbh Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff.
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
AU5609998A (en) * 1997-01-10 1998-08-03 Abbott Laboratories Tablet for the controlled release of active agents
US20010055613A1 (en) * 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
US6706283B1 (en) * 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
EA004370B1 (ru) * 1999-12-23 2004-04-29 Пфайзер Продактс Инк. Лекарственная форма с высвобождением лекарства под действием гидрогеля
US6720005B1 (en) * 2000-07-07 2004-04-13 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Coated, platform-generating tablet
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
EA005537B1 (ru) * 2001-07-10 2005-04-28 Тева Фармасьютикал Индастриес Лтд. Система доставки лекарственного вещества по нулевому порядку, нулевому порядку - двухстадийной, возрастающей или убывающей доставки препарата
GB0117618D0 (en) * 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form
ITMI20020514A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
ITMI20020515A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema per il rilasco controllato di uno o piu' principi attivi
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
AP2006003602A0 (en) * 2003-09-19 2006-04-30 Sun Pharmaceutical Ind Ltd Oral drug delivery system
US20060193911A1 (en) * 2005-02-28 2006-08-31 Penwest Pharmaceuticals Co., Controlled release venlafaxine formulations
CN101146521A (zh) * 2005-03-14 2008-03-19 太阳医药高级研究有限公司 提供包含纤维素和甲基丙烯酸衍生物包衣的口服药物输送系统
CN101188999B (zh) * 2005-06-03 2012-07-18 尹格莱特股份有限公司 用于递送分散在分散介质中的活性物质的药物传递系统
PL116330U1 (en) * 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
WO2007057762A2 (en) * 2005-11-16 2007-05-24 Pfizer Limited Osmotic bi-layer tablet
US20070264346A1 (en) * 2006-02-16 2007-11-15 Flamel Technologies Multimicroparticulate pharmaceutical forms for oral administration

Similar Documents

Publication Publication Date Title
JP2011512349A5 (OSRAM)
CN111405895B (zh) 一种控释药物组合物及其制备方法
WO2009122431A3 (en) Oral controlled release tablet with reduced burst effect
KR101241624B1 (ko) 안지오텐신-ⅱ-수용체 차단제를 포함하는 약제학적 제제
JP4706785B2 (ja) 経口投与用粒子状医薬組成物
CN103096881B (zh) 含有具有不愉快味道的药物的膜制剂
JP5986984B2 (ja) 積層錠剤、その製造方法、および、層剥離抑制方法
US20110229570A1 (en) Orally rapidly disintegrating tablet and process for producing same
JP2010527347A5 (OSRAM)
JP2017128614A5 (OSRAM)
WO2008140460A1 (en) Solid form
CN101711752A (zh) 一种苯并异噁唑类衍生物的控释制剂及其制备方法
HRP20240564T1 (hr) Novi farmaceutski sastav
WO2013030725A1 (en) Methods for treating cardiovascular disorders
WO2004064815A8 (en) Oral dosage formulation
JP2016516698A5 (OSRAM)
KR20130010463A (ko) 고형 제제
JP2005506987A5 (OSRAM)
CN103948557A (zh) 一种新型控释片
KR20130010464A (ko) 고형 제제
WO2007132296B1 (en) Multilayer tablet
KR20110130441A (ko) 고형 제제
EP2806861A1 (en) In-situ multilayered tablet technology
RU2221559C1 (ru) Препарат диклофенак натрия длительного действия
RU2611339C2 (ru) Фармацевтические композиции с пролонгированным высвобождением для лечения цереброваскулярных расстройств